Tilray Inc. ($TLRY) Stock Forecast: Down 5.0% Today

What is Tilray Inc.?

Tilray Brands, Inc. (TLRY) is a significant player in the Canadian cannabis market, with a market capitalization of $1.13 billion. Despite its potential upside and increased institutional investments, the stock experienced a substantial bearish movement today.

Why is Tilray Inc. going down?

TLRY stock is down 5.0% on Dec 29, 2025 20:50

• Tilray's stock price decreased by 4.2%, closing at $10.085, which was below the broader market performance.
• Analysts have given a consensus "Hold" rating with an average price target of $20, showing caution among investors.
• The drop in stock price may be linked to lower-than-expected performance and uncertainties about the upcoming second fiscal quarter results.
• Despite optimistic prospects for potential cannabis rescheduling and hemp-derived products, investors might be hesitant due to recent underperformance and competition in the AI sector.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Brands, Inc. (TLRY)’s Potential Upside Meets a Cautious Consensus

Tilray Brands, Inc. (TLRY) has garnered mixed analyst sentiment, with a majority assigning a Hold rating and a median price target of $19, representing an 88.49% upside potential. An analyst from Bernstein reiterated a 'Market Perform' rating and significantly raised the price target due to potential cannabis rescheduling and revised hemp-derived cannabinoid product definitions. The article highlights Tilray's positioning in the Canadian cannabis market but suggests other AI stocks might offer better returns and less downside risk.

https://www.insidermonkey.com/blog/tilray-brands-inc-tlrys-potential-upside-meets-a-cautious-consensus-1666580/?amp=1

Tilray Brands, Inc. (NASDAQ:TLRY) Receives Consensus Rating of "Hold" from Brokerages

Tilray Brands, Inc. (NASDAQ:TLRY) has received a consensus "Hold" rating from seven brokerages, with an average 12-month price target of $20.00. Institutional investors have recently increased their stakes, with hedge funds and other institutions collectively owning about 9.35% of the stock. At market open, Tilray shares were down approximately 4.2%, trading at $10.09, and the company has a market capitalization of $1.13 billion.

https://www.marketbeat.com/instant-alerts/tilray-brands-inc-nasdaqtlry-receives-consensus-rating-of-hold-from-brokerages-2025-12-26/

Tilray Brands Inc. Stock Sheds 3.6%, Underperforms Market

Tilray Brands Inc. (TLRY) stock experienced a 3.6% drop, underperforming the broader market. This news comes alongside Unity Software (U.US) reporting its fourth-quarter financial results, with revenue increasing 35% year-over-year to $609 million, though it reported a quarterly loss of 66 cents per share.

https://news.futunn.com/en/post/66617700/tilray-brands-inc-stock-sheds-3-6-underperforms-market

Tilray Brands (NASDAQ:TLRY) Shares Down 4.2% - Here's Why

Tilray Brands (NASDAQ: TLRY) shares dropped 4.2% during mid-day trading on Wednesday, trading as low as $9.97 and closing at $10.085. This decline occurred on a trading volume 27% below its daily average, with approximately 4.51 million shares changing hands. The stock holds a consensus "Hold" rating from analysts with an average target price of $20.

https://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-shares-down-42-heres-why-2025-12-24/

Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026

Tilray Brands will announce its second fiscal quarter results, which ended on November 30, 2025, after the financial markets close on Thursday, January 8, 2026. The company will host a live conference call and audio webcast at 4:30 PM Eastern Time on the same day to discuss these results. Investors can submit and upvote questions ahead of time via Robinhood and Say Technologies until January 7, 2026.

https://www.sahmcapital.com/news/content/tilray-brands-to-announce-second-quarter-fiscal-year-2026-financial-results-on-january-8-2026-2025-12-22

Trending Today

Beyond Meat Inc. ($BYND) Stock Forecast: Down 7.5% Today

Silver ($XAG) Commodity Forecast: Up 5.3% Today

CSX Corporation ($CSX) Stock Forecast: Down 1.0% Today

TripAdvisor Inc. ($TRIP) Stock Forecast: Up 5.0% Today

NASDAQ-100 ($NDX) Index Forecast: Up 0.3% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 5.3% Today

McCormick & Company Incorporated ($MKC) Stock Forecast: Up 0.0% Today

Rivian Automotive Inc. ($RIVN) Stock Forecast: Down 5.4% Today

Bumble Inc. ($BMBL) Stock Forecast: Up 6.2% Today

Lemonda Inc. ($LMND) Stock Forecast: Down 5.0% Today

Tilray Inc. Price History

22.11.2025 - TLRY Stock was down 5.2%

• The bearish movement in Tilray's stock today could be attributed to the company's ongoing financial struggles, lack of earnings, and cash burn.
• Despite recent positive sentiment and stock rises driven by potential easing of marijuana restrictions and strategic developments, the market may be reacting to the underlying financial challenges faced by Tilray.
• The uncertainty surrounding U.S. marijuana reform, particularly the reliance on federal rescheduling rather than outright legalization, might be causing investors to exercise caution and reevaluate their positions in Tilray.

22.11.2025 - TLRY Stock was down 6.0%

• The bearish movement in TLRY stock today could be attributed to the anticipation and uncertainty surrounding the upcoming financial results announcement.
• Comments on Tilray's lack of earnings may have contributed to investor skepticism and selling pressure on the stock.
• Despite the positive news about Tilray's formation of Tilray Medical USA, Inc. to advance its U.S. medical cannabis operations, the overall market sentiment may have been overshadowed by concerns about the company's financial performance and growth strategy.
• The market might be reacting to the realization that Tilray's growth is primarily driven by acquisitions in the alcohol sector rather than its struggling cannabis segment, raising doubts about the company's long-term sustainability.

19.11.2025 - TLRY Stock was down 8.4%

• There was a significant bearish movement in TLRY stock today, possibly due to investors cashing out profits following a recent surge triggered by indications of potential marijuana reclassification by a former President.
• Market reaction may be influenced by experts warning that moving cannabis to Schedule III doesn't mean federal legalization, causing uncertainty and prompting selling.
• Despite forming Tilray Medical USA, Inc. to expand U.S. medical cannabis operations, the company's financial difficulties, ongoing losses, and focus on alcohol acquisitions rather than cannabis growth could be fueling negative market sentiment.
• The uncertain regulatory landscape for cannabis, paired with a recent reverse split and general market instability, may be intensifying downward pressure on Tilray's stock price.

16.11.2025 - TLRY Stock was up 5.8%

• TLRY experienced a substantial surge of 44.1% following potential discussions of a reclassification of marijuana at a federal level. This positive news not only impacted TLRY but also other cannabis stocks like Canopy Growth and Aurora Cannabis.
• The company's recent execution of a 10-for-1 reverse stock split, aimed at reducing its float and ensuring compliance with Nasdaq regulations, also influenced the bullish movement by boosting investor confidence.
• Surpassing its 200-day moving average and holding a Zacks Rank #3 (Hold) indicate a potential long-term bullish trend for TLRY, supported by positive earnings estimate revisions and strategic expansion into new markets.
• While the future looks promising, caution is advised due to the volatility in the cannabis sector. It is advisable for investors to closely monitor the situation until official confirmation and details regarding the potential policy change are disclosed.

24.11.2025 - TLRY Stock was down 5.3%

• The upcoming announcement of Tilray Brands' second fiscal quarter financial results has likely created uncertainty and caution among investors, leading to a sell-off of the stock.
• Despite the recent drop, the stock has shown a notable increase over the past month, indicating potential profit-taking by traders.
• The lack of substantial analysis suggests a disconnect between market sentiment and speculative opinions on whether the stock's fall presents a buying opportunity.
• Investors are eagerly awaiting the earnings report, with expectations of a significant increase in EPS, but a slight decrease in revenue compared to the previous year, adding to the volatility surrounding the stock.

17.11.2025 - TLRY Stock was down 8.1%

• Despite positive developments regarding the potential reclassification of marijuana from Schedule I to Schedule III, Tilray faced a bearish movement.
• The surge in Tilray's stock price post speculations on marijuana reclassification by Trump might have prompted profit-taking actions among investors, leading to the bearish movement.
• Uncertainty surrounding the final reclassification decision and profit-taking activities likely contributed to Tilray's stock price decline today.
• The market sentiment towards Tilray remains optimistic, anticipating future ease in federal restrictions and potential improvements in profitability.

17.11.2025 - TLRY Stock was up 16.2%

• TLRY stock surged by 44.1% due to speculation about a possible reclassification of marijuana as a Schedule III substance through an executive order.
• The surge in TLRY's stock price was driven by optimism about relaxed federal restrictions on cannabis and the potential business opportunities it could bring for companies in the industry.
• Despite the initial rally, the stock price cooled off as White House officials indicated that no final decision had been reached, showcasing the uncertainty surrounding the potential reclassification of marijuana. This led to profit-taking and a moderation in TLRY's price movement.
• Tilray's CEO emphasized the importance of clear regulation in the cannabis industry, especially regarding THC-infused drinks. He highlighted how regulatory clarity could benefit legitimate companies by ensuring quality standards and reducing illicit market activity.

12.11.2025 - TLRY Stock was up 31.7%

• The introduction of Redecan's Amped Live Resin Liquid Diamond 1g 510 cartridges in Canada has sparked enthusiasm and market interest, contributing to Tilray's upward movement.
• Positive developments related to the legalization of home marijuana cultivation in Florida and potential changes in federal cannabis regulations have bolstered investor confidence in Tilray's future outlook.
• Despite facing challenges such as increased expenses and a stock price decline, Tilray's expansion strategies and focus on evolving into a diversified consumer packaged goods (CPG) company have resonated well with traders and investors, driving the bullish market performance observed today.
• The company's adept handling of regulatory shifts and its ability to seize opportunities within the cannabis sector are expected to be key factors influencing its stock performance in the immediate future.

15.11.2025 - TLRY Stock was down 5.2%

• The bearish movement in TLRY today could be attributed to profit-taking by investors after a series of strong bullish movements.
• Despite the recent surge in TLRY's stock price, the lack of a definitive catalyst or news today may have led to a natural correction in the market.
• The mixed views from analysts regarding TLRY's future performance, balancing policy tailwinds with execution challenges, could have also contributed to the bearish movement as investors reassess the stock's potential.

29.11.2025 - TLRY Stock was down 5.0%

• Tilray's stock price decreased by 4.2%, closing at $10.085, which was below the broader market performance.
• Analysts have given a consensus "Hold" rating with an average price target of $20, showing caution among investors.
• The drop in stock price may be linked to lower-than-expected performance and uncertainties about the upcoming second fiscal quarter results.
• Despite optimistic prospects for potential cannabis rescheduling and hemp-derived products, investors might be hesitant due to recent underperformance and competition in the AI sector.

29.11.2025 - TLRY Stock was down 5.0%

• Tilray's stock experienced a 4.2% decline in value during mid-day trading, closing at $10.085.
• Analysts have assigned a consensus "Hold" rating to Tilray, with a median price target of $20, indicating a potential upside of 88.49%.
• The bearish movement could be attributed to the cautious sentiment among analysts, despite potential positive developments such as cannabis rescheduling and revised product definitions.
• The upcoming announcement of Tilray's second fiscal quarter results may also be contributing to investor uncertainty and selling pressure on the stock.

19.11.2025 - TLRY Stock was down 23.1%

• Today's bearish movement in TLRY may be due to investors taking profits following a recent surge influenced by discussions of President Trump contemplating cannabis reclassification.
• Though there is optimism about regulatory changes, the speculative nature of the cannabis industry and uncertainties regarding federal legalization may be causing some traders to proceed with caution.
• Volatility in TLRY's stock price could be impacted by option traders anticipating significant year-end movements, leading to short-term market fluctuations.
• It is important for investors to stay informed about any official announcements on cannabis regulations to navigate the current market volatility effectively.